AmblyoPlay Offers Vision Therapy Solution for Lazy Eye in U.S.

By


More Images

 
Product: AmblyoPlay
Top Line: AmblyoPlay, a home-based vision therapy solution for children and adults with amblyopia (lazy eye), mild strabismus (crossed or turned eye) or convergence insufficiency (eyes unable to focus together), is launching its software-based vision therapy solution in the U.S. market.
Close Up: AmblyoPlay complements in-office vision therapy and increases at-home vision therapy participation through gamification. Children use interactive gaming software to play therapeutic games and exercises every day for 30 minutes while wearing special red and blue glasses. They are rewarded with tokens they can exchange for physical awards that are sent to their home. The program—available via Windows and Mac computers, Android tablets and iPads—stimulates the eye muscles through two 15-minute sessions per day.
“We realized quickly that for our target age group – children aged four to 14 – making the therapy engaging and rewarding was the first step in supporting parents and doctors as they treat amblyopia,” said Žan Menart, CEO of AmblyoPlay. “Lazy eye can lead to depth perception and vision problems that have long-lasting effects, like reading and learning difficulties, social trauma, disadvantages playing sports, difficulty obtaining a driver’s license and more.
“AmblyoPlay does not replace the expertise provided by a doctor—eyecare specialists are essential to any eye diagnosis or vision therapy,” said Menart. “Our software serves as another tool to improve visual function of patients and improve their quality of life.”
Vital Stats: Users have three subscription options for gaining access to AmblyoPlay—three months, six months or a year. The different durations address the unique needs of the user, which can be affected by the user’s age, the severity of their vision problem and how regularly they complete the vision therapy exercises. Parents can monitor the progress of their child through AmblyoPlay’s automated progression tracker and share the results with their child’s doctor at subsequent eye examinations.
AmblyoPlay was developed by eyecare startup Smart Optometry, creators of the Smart Optometry app for eye screening and diagnosis, eye therapy and eye damage prevention. It is currently used by 75,000 doctors worldwide.
Pricing for AmblyoPlay starts at $110 for a three-month subscription and is available for purchase on AmblyoPlay’s website.
www.amblyoplay.com